Evaluation of ongoing oxycodone abuse among methadone-maintained patients

Journal of Substance Abuse Treatment

Volumn 35, Issue 4, 2008, Pages 451-456

  Dunn, Kelly E ^a   Sigmon, Stacey C ^a,b   McGee, Mark R ^a   Heil, Sarah H ^a,b   Higgins, Stephen T ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Methadone maintenance; Oxycodone; OxyContin; Prescription opioid; Urinalysis testing

Indexed keywords

METHADONE; OXYCODONE;

ARTICLE; CLINICAL FEATURE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; QUALITY CONTROL; TEST STRIP; URINALYSIS;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; OUTPATIENTS; OXYCODONE; REAGENT STRIPS; SUBSTANCE ABUSE DETECTION; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 54249085071     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.12.006     Document Type: Article

References (31)

1. Abadie J.M., Allison K.H., Black D.A., Garbin J., Saxon A.J., and Bankson D.D. Can an immunoassay become a standard technique in detecting oxycodone and its metabolites?. Journal of Analytical Toxicology 29 (2005) 825-829
2. Backer R.C., Monforte J.R., and Poklis A. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine. Journal of Analytical Toxicology 29 (2005) 675-677
3. Bailes M., and Lowery C. Practical issues of program organization and operation. In: Strain E.C., Stitzer M.L., et al. (Eds). The treatment of opioid dependence (2006), The Johns Hopkins University Press, Baltimore, MD 365-397
4. Belding M.A., McLellan A.T., Zanus D.A., and Incmikoski R. Characterizing "non-responsive" methadone patients. Journal of Substance Abuse Treatment 15 (1998) 1-8
5. Birnbaum H.G., White A.G., Reynolds J.L., Greenburg P.E., Zhang M., Vallow S., et al. Estimated costs of prescription opioid analgesic abuse in the United Stated in 2001. The Clinical Journal of Pain 22 (2006) 667-676
6. Brands B., Blake J., Sproule B., Gourlay D., and Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 73 (2004) 199-207
7. Carise D., Degosh K.L., McLellan A.T., Camilleri A., Woody G.E., and Lynch K.G. Prescription Oxycontin abuse among patients entering addiction treatment. American Journal of Psychiatry 164 (2007) 1750-1756
8. Center for Substance Abuse Treatment (CSAT). Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048 (2005), Substance Abuse and Mental Health Services Administration, Rockville, MD
9. Chermack S.T., Roll J., Reilly M., Davis L., Kilaru U., and Grabowski J. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug and Alcohol Dependence 59 (2000) 43-49
10. Cicero T.J., Inciardi J.A., and Muñoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. The Journal of Pain 6 (2005) 662-672
11. Compton W.M., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81 (2006) 103-107
12. Craig R.J., and Olson R.E. Predicting methadone maintenance treatment outcomes using the Addiction Severity Index and the MMPI-2 Content Scales. American Journal of Drug and Alcohol Abuse 30 (2004) 823-839
13. Federal Register 42 CRF Part 8. Opioid drugs in maintenance and detoxification treatment of opiate addiction: Final rule. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (2001)
14. Haller C.A., Stone J., Burke V., Branch J., Chen K., and Gross S. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory. Journal of Analytical Toxicology 30 (2006) 106-111
15. In: Hawks R.L., and Chiang C.N. (Eds). Urine testing for drugs of abuse. NIDA Research Monograph 73 (1986), Department of Health and Human Services, Rockville, MD
16. Katz N., and Fanciullo G.J. Role of urine toxicology testing in the management of chronic opioid therapy. The Clinical Journal of Pain 18 (2002) S76-S82
17. Levy S., Sherritt L., Vaughan B.L., Germak M., and Knight J.R. Results of random drug testing in an adolescent substance abuse program. Pediatrics 119 (2007) e843-e848
18. Miller N.S., and Greenfeld A. Patient characteristics and risk factors for development of dependence on hydrocodone and oxycodone. American Journal of Therapeutics 11 (2004) 26-32
19. Morral A.R., Belding M.A., and Iguchi M.Y. Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug and Alcohol Dependence 55 (1999) 25-33
20. Office of Applied Studies. Substate estimates from the 2002-2004 National Surveys on Drug Use and Health (2006), Substance Abuse and Mental Health Services Administration, Rockville, MD
21. Office of National Drug Control Policy (ONDCP). State of Vermont: Profile of drug indicators (2003), Drug Policy Information Clearinghouse, Rockville, MD
22. Passik S.D., Hays L., Eisner N., and Kirsh K.L. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. Journal of Pain and Palliative Care Pharmacotherapy 20 (2006) 5-13
23. Peles E., Schreiber S., and Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence 82 (2006) 211-217
24. Rosenblum A., Parrino M., Schnoll S.H., Fong C., Maxwell C., Cleland C.M., et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence 90 (2007) 64-71
25. Sigmon S.C. Characterizing the emerging population of prescription opioid abusers. American Journal on Addiction 15 (2006) 208-212
26. Stitzer M.L., and Sigmon S.C. Other substance use disorders: Prevalence, consequences, detection and management. In: Strain E.C., and Stitzer M.L. (Eds). The treatment of opioid dependence (2006), The Johns Hopkins University Press, Baltimore, MD 365-397
27. Substance Abuse and Mental Health Services Administration (SAMHSA). Overview of findings from the 2004 National Survey on Drug Use and Health (Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061) (2005), National Clearing House for Alcohol and Drug Information, Rockville, MD
28. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194) (2006), National Clearing House for Alcohol and Drug Information, Rockville, MD
29. Villafranca S.W., McKellar J.D., Trafton J.A., and Humphreys K. Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence 83 (2006) 218-224
30. Wasserman D.A., Korcha R., Havassy B.E., and Hall S.M. Detection of illicit opioid and cocaine use in methadone maintenance treatment. American Journal of Drug and Alcohol Abuse 25 (1999) 561-571
31. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on problems of drug dependence taskforce on prescription opioid nonmedical use and abuse: Position statement. Drug and Alcohol Dependence 69 (2003) 215-232